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Abstract
Motivation: The identification of protein and gene names (PGNs) from the scientific literature requires semantic
resources: Terminological and lexical resources deliver the term candidates into PGN tagging solutions and the gold
standard corpora (GSC) train them to identify term parameters and contextual features. Ideally all three resources,
i.e. corpora, lexica and taggers, cover the same domain knowledge, and thus support identification of the same types
of PGNs and cover all of them. Unfortunately, none of the three serves as a predominant standard and for this reason it
is worth exploring, how these three resources comply with each other. We systematically compare different PGN
taggers against publicly available corpora and analyze the impact of the included lexical resource in their
performance. In particular, we determine the performance gains through false positive filtering, which contributes to
the disambiguation of identified PGNs.
Results: In general, machine learning approaches (ML-Tag) for PGN tagging show higher F1-measure performance
against the BioCreative-II and Jnlpba GSCs (exact matching), whereas the lexicon based approaches (LexTag) in
combination with disambiguation methods show better results on FsuPrge and PennBio. TheML-Tag solutions
balance precision and recall, whereas the LexTag solutions have different precision and recall profiles at the same
F1-measure across all corpora. Higher recall is achieved with larger lexical resources, which also introduce more noise
(false positive results). TheML-Tag solutions certainly perform best, if the test corpus is from the same GSC as the
training corpus. As expected, the false negative errors characterize the test corpora and – on the other hand – the
profiles of the false positive mistakes characterize the tagging solutions. Lex-Tag solutions that are based on a large
terminological resource in combination with false positive filtering produce better results, which, in addition, provide
concept identifiers from a knowledge source in contrast toML-Tag solutions.
Conclusion: The standardML-Tag solutions achieve high performance, but not across all corpora, and thus should
be trained using several different corpora to reduce possible biases. The LexTag solutions have different profiles for
their precision and recall performance, but with similar F1-measure. This result is surprising and suggests that they
cover a portion of the most common naming standards, but cope differently with the term variability across the
corpora. The false positive filtering applied to LexTag solutions does improve the results by increasing their precision
without compromising significantly their recall. The harmonisation of the annotation schemes in combination with
standardized lexical resources in the tagging solutions will enable their comparability and will pave the way for a
shared standard.
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Introduction
The integration of the biomedical literature into the
infrastructure of other biomedical data resources requires
the identification of entities and concepts, such as pro-
teins and gene named entities [1,2]. Furthermore, the
entities have to be linked to specific database entries to
achieve interoperability between all data resources (called
“grounding” or “normalisation”) [3-5]. Once genes and
other entities have been correctly identified, the different
data resources and information types can be explored in
concerto: Genes can be attributed with known facts such
as associated diseases or novel drug candidates [6,7].
“Which gene did youmean?”
Biologically, a gene is given by one or several genetic
sequences that reside on one or several locations on the
DNA (genetic loci). According to semantic formalisms
a gene is a disposition which is described by the given
genetic sequence. By contrast, a protein, a gene product,
is a class of molecules with specific properties: composed
of amino acids, having a structure and specific functions.
A gene can be analysed by sequencing, but the observa-
tion of a protein and its functions requires more complex
experimental setups. Eventually, observations about pro-
teins (and genes) are kept in reference databases, like
UniProt [8] for proteins or the NCBI Gene database [9]
(formerly known as Entrez Gene), which also contribute
with unique identifiers for grounding or normalisation
[10].
Scientists frequently do not distinguish between the
mention of a gene or a protein in their publications, since
the gene is – in general – transcribed and translated into a
protein anyways, i.e. the gene produces multiple instances
of this particular protein type, which then exposes their
function [11]. In principle, we should have for every pro-
tein type a unique database entry which contains the
reference information such as a unique identifier, the pro-
tein properties and also the names (“labels”) that would
help to recognize the protein type in text, called pro-
tein and gene names (PGNs). Unfortunately, the existing
resources are not quite as comprehensive yet.
More than 500,000 database entities are available that
refer to protein types, which also contribute with sev-
eral million names, synonyms, acronyms, hypernyms and
morphological term variants [12]. These names certainly
comply with established nomenclature guidelines, but the
reporting in the scientific literature is not similarly stan-
dardised and produces new term variants on a daily basis
[13-15].
Standards for protein and gene names
There are several “standard” approaches to validate a
PGN identified in text. A first approach is to con-
sult the naming guidelines [16-18], to discover that
the name (1) may represent a recognized macro-
molecule (e.g., “hemoglobulin”, “prolactin”), (2) may state
the function of the gene or protein (e.g., “methyl-
transferase”), (3) may state part of the structure of
a protein (e.g., “Cytochrome c oxidase subunit 2”),
(4) may indicate that the protein is part of a pro-
cess (e.g., “Mitochondrial fission process protein 1”),
(5) may indicate its action on a target (e.g., “DNA gyrase
inhibitor”), (6) may induce a phenotype (e.g., “protein
hunchback”), (7) may express chemical or physical prop-
erties (e.g., “37.8 kD protein”), or (8) may just be similar
to another known protein or gene (e.g., “Myc homolog
protein”).
A second and simpler approach, which is another stan-
dard, would be looking up the name in a reference
database, where the PGN may be linked to a single entry
(“unique name”), to several data entries (“polysemous
term”), or to no entry at all (“unknown PGN”). A third
approach would imply using a PGN tagger, e.g. “Banner”
[19] a state of the art machine learning based tagger, and
any finding of a PGN would be considered a true positive
ignoring for the moment missed terms (false negatives,
FN) and the wrongly identified terms (false positives, FP).
Other tagging solutions have been suggested and tested as
well, but may be used to a lesser degree [20]. A prelim-
inary comparison of ML-Tag solutions has already been
performed [21], but was executed to judgemethods for the
identification of protein interactions from the scientific
literature, and as a consequence did not cover the same
scope as this analysis.
As a last approach, the different GSCs could be con-
sulted, which have been produced to denote the correct
mention of a PGN in the scientific literature. The fol-
lowing GSCs have to be considered (cf. Table 1): (1)
Jnlpba [22] (2004) which stems from the Genia corpus,
(2) BioCreative-II [23] (BC2, 2007) for human PGNs, (3)
PennBio corpus [24] (2006–2007) about oncology, and
(4) FsuPrge corpus [25] (2009) on gene-regulatory events.
The CRAFT corpus [26] has not been considered in this
study, since it covers full text articles and was not yet
available during the experimental phase of this work.
Considering the different solutions to represent the
same or similar standards, the question arises, how these
Table 1 A number of gold standard corpora have been
delivered to the public for the evaluation of PGN tagging
solutions
Name Release # Annot. # Units Topic
Jnlpba 2004 6,142 401 abs. Subset of Genia
BioCreative-II 2005 5,144 4,171 sent. Human proteins
PennBio 2006–07 18,148 1,414 abs. Oncology
FsuPrge 2009 59,483 3,236 abs. Gene regulatory
processes
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different solutions relate to each other. Can we character-
ize, which portion of the semantics representation they
share and where they differ? Although Banner is only one
piece in the puzzle, it can be used as the starting point:
first as a means to judge the compliance of the GSCs and
second, as a means to compare against other PGN tagging
solutions measured across all corpora.
Note that all evaluations are concerned with the surface
forms of PGNs in text and in the other semantic resources,
thus our analysis is focused to the identification of gene
mentions. From a different angle, the presented study still
allows to derive, whether or not a PGN mention given
by a tagging solution is linked to a concept identifier (see
Table 2), which is deemed more precious than the pure
identification of a PGN.
Is Banner the best tagging solution?
In the search of the best tagging solution, a number of
hypotheses and test scenarios can be evaluated. State of
the art PGN tagging solutions like Banner have not fully
solved the PGN tagging task yet, the question remains
whether it is possible to introduce a solution that per-
forms better than Banner. It is easy to derive that Banner
will certainly perform best on the BioCreative II corpus,
which has been used to train the tagging solution, but how
big is the performance loss, when we evaluate it on other
GSCs?
It is also possible to evaluate PGN tagging solutions
that have been trained on other GSC, e.g. Abner [20]
(BioCreative-I) and Abner (Jnlpba), and compare them
against Banner, leading to the obvious assumption that
each solution may achieve better performance on the test
corpus of the GSC they have been trained on. But which
PGN tagger will perform best across all GSCs? The answer
to this question requires that all PGN tagging solutions are
tested against all GSCs.
It is also possible to explore PGN tagging solutions
that have not been trained on any of the GSCs, e.g. dic-
tionary lookup based solutions from the Whatizit [27]
infrastructure. Several taggers are available that can be
distinguished according to the lexical resources that have
been incorporated into the annotation solution. Two
questions arise: Which one performs best and on which
GSC, and is it possible to correlate the tagging perfor-
mance with the type of lexical resource that has been
incorporated?
Another observation results from the previous consid-
erations. If we test a selection of PGN tagging solutions
across different GSCs, then we will find out that the tag-
gers miss annotations (FNs) that are specific for one GSC
in contrast to another, and that some tagging solutions
are more alike in the production of unconfirmed anno-
tations (FPs) than others. It becomes clear, that the PGN
taggers may have similar FP profiles and a given GSC may
induce similar FN profiles. Are these profiles giving us
better insights, which setup for a PGN tagging solution is
required to achieve the best performance on a given cor-
pus or are selected corpora even more characteristic for a
given set of PGNs after all? Even beyond this result, can
we better analyse what distribution of PGN representa-
tions we would have to expect in the scientific literature in
general?
It becomes clear that the comparison of as many PGN
tagging solutions against as many GSCs as available leads
to a matrix where each solution shows its best fit to a GSC
and eventually, it becomes possible to reverse engineer
Table 2 The PGN tagging solutions are incorporate different components, i.e. lexical resources or trained
machine-learning based entity recognizers
Tagger Acronym Tagger Lexical # Lexical Id Training FP
name type resource entries data filter
Banner ML – – No BC2 Banner
Chang2 Ch2 ML – – No BC2 Chang2
Abner (BC1) ML – – No BC1 Abner (BC1)
Abner (Jnlpba) ML – – No Jnlpba Abner (Jnlpba)
SwissProt SP Lex SwissProt 228,893 Yes – BNC
SwissProt (GP7) Lex GP7 868,050 Yes – BNC
BioLexicon Lex BioLexicon 653,212 Yes – BNC
GeneProt 7.0 GP7 Lex GP7 1,725,500 Yes – BNC
Wh-Ukpmc Lex+ML SwissProt 228,893 Yes – BNC, Chang2
Wh-Ukpmc (GP7) WH7 Lex+ML GP7 868,050 Yes – BNC, Chang2
Gnat (human) Lex+ML Human genes Yes BC2 –
Gnat (all) Lex+ML 11 species 80,000 Yes BC2 –
Gnat-GN (all) Lex+ML 11 species 80,000 Yes BC2 –
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which resources induce a PGN tagging solution that
produces the best results against the given GSC.
How to evaluate a PGNmention?
A priori, it is only necessary to apply all PGN tagging
solutions against all corpora, count the true positives,
false positives and false negatives and finally calculate
precision, recall and F1-measure. Any GSC – in its own
rights – would claim this result as the only correct solu-
tion. Unfortunately, as it is often the case, a more complex
solution is required to produce results that are indepen-
dent from a single corpus.
Ideally, we would like to measure the correct assign-
ment of an identifier to the PGN mention in the text,
where the identifier points to an entry in the reference
database [10]. Since PGN mentions are often polysemous
and have been reused in a number of database entries, it
is impossible to derive automatically the identifier which
should be the preferred choice for the author. A recent
experiment has also shown that authors as well fail to
use database entries – even when supported by experts
for doing so – and rather prefer to use terminology only
when specifying PGNs in theirs manuscripts [28-30]. It
is in the same way impossible to make a clear distinc-
tion between gene mentions and protein mentions, and
name ambiguities between genes and proteins, e.g. ‘hypA’
versus ‘HypA’, may result from the annotation guidelines
[11].
The term boundaries are certainly crucial for the char-
acterization of the term and its semantics. Again, it
has been claimed that the difficulties in determining
the correct term boundaries do result from the com-
plexity of the naming guidelines, which – in this case
– have been used for the production of a GSC [11].
As an example, the organism names preceding a pro-
tein name may or may not be part of the protein name.
The authors address the problems by defining the tag-
ging of proteins as the prime target of the extraction
task, and also distinguish the protein tags and the long-
form tags as two annotation types, where the latter is
formed by optionally extending the boundaries of the pro-
tein tag whenever the name boundaries are difficult to
determine.
In essence, exact boundary matching gives clear evalua-
tion guidelines, but will ignore term variability, i.e. ignores
alternative annotations by a PGN tagging solution that
does cope with term variability.When relaxing the bound-
ary criteria, either by treating morphological term vari-
ability as a single entry (e.g. “HZF-7” vs. “HZF-7 protein”)
or by the use of flexible matching [31] (e.g. cosine similar-
ity, nestedness) or by allowing alternative term mentions
(see BioCreative II, Alternative Gene List) the perfor-
mance of the tagging solutions increases, but the precise
interpretation of the results is reduced.
Background
The following section gives an overview on different
solutions for PGN tagging. In principle, a classifier can
be trained on a GSC and then correctly identifies the
PGN boundaries (“mention identification”), but would not
attribute a database identifier to the PGN mention. The
latter requires at least the use of one or more lexical
resources.
PGN tagging solutions
Yamamoto distinguishes three different basic approaches
for the identification of bio-entities: (a) exact and approx-
imate string matching of entities [32,33], (b) handcrafted
rule-based approaches [34,35], and (c) machine learning
solutions [36,37]. In addition, hybrid methods exist that
integrate dictionaries with machine-learning approaches
[38-40].
In principle all gene taggers fulfill a number of specific
tasks. In the first place they identify a stretch of text that
appears to represent a gene [41]. This judgment requires
that the morphological and syntactical structure of the
gene is identified from text [42,43]. The second step is
the use of the contextual information to achieve term dis-
ambiguation or normalization of the named entity to a
concept identifier [44,45]. Both results can be achieved
with a single processing step, for example in the use of
dictionary based methods, but under-perform in terms of
context-sensitive disambiguation of terms and entities in
comparison to the ML approaches.
One solution for the gene identification is the use of a
terminological resource that covers the full set of PGNs
[45]. Such resources have been generated from public sci-
entific databases, e.g. from UniProtKb, or from a set of
public resources in combination or can also be produced
from the scientific literature [46-48]. The size of the ter-
minological resources is crucial for the identification task,
since only a comprehensive resource can ensure that all
entities are identified [49]. On the other hand, a larger ter-
minological resource increases the noise ratio of the gene
tagger, since less common and ambiguous gene names
raise the false positive rate. Last but not least, the use
of existing terminological resources leads to the advan-
tage that the gene can be linked to their database resource
[15,44,50,51], which provides further relevant information
about the gene.
As mentioned before, typical machine-learning solu-
tions solve the mention identification task and have been
trained and tested on a GSC [19,52,53]. Hybrid methods
require the integration of a dictionary and a machine-
learning approach [38-40].
Normalising gene entities
The PGN tagging solutions provide one or several types of
normalisation. The first type of normalisation only affects
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the mention in text. The PGN tagger could provide a left-
most or right-most longest match to a PGN or could just
instantiate the normalisation according to a GSC (“men-
tion normalisation”). In the second type of normalisation,
the PGN tagger would ensure that the mention exists in
a terminological resource (“lexical lookup normalisation”,
see Table 3), where thematchmay ormay not consider any
morphological variability (HZF 7 vs. HZF1-7 vs. HZF/7)
or other modifications to the term.
The dictionary-based tagging solutions make use of dif-
ferent terminological resources and the lexical resources
have been compared as described here (Table 3). One lex-
ical resource has been used as a component in a tagging
solution (called “tagger” in the in Table 3) and has been
applied to the lexical resource to annotate the content
(called “corpus”). Two different methods for the match-
ing have been applied: (1) exact matching (upper part of
the table), and (2) matching with morphological variabil-
ity (“alias” matching, lower part). The cross-tagging shows
the intersections between the different resources and
overall it becomes clear, which terminological resource
comprises fully or partially one of the other resources.
The third type of normalisation, which is the most
advanced one, would select the most appropriate refer-
ence to a database entry ("concept normalisation"), but
would not allow mulitple references to database entries.
Different approaches have been proposed to normalize
the entities, but no complete solution has been presented
yet. Approaches that anticipate normalization are more
restrictive in contrast to other PGN taggers, since they
attempt to narrow the selection down to the most spe-
cific assignment amongst all candidates. Normalisation
approaches include the following solutions: (1) delivery
of all the entities that could be resolved to the PGN, (2)
selection of a species that is automatically used for the
normalization independently from the mention of any
other species in the text, (3) selection of the species from
the text that could indicate the right resolution, and (4) use
of genomic information and database information for the
gene normalization [44,51,54-57]. A toolkit for the nor-
malisation is available from [58] and the evaluation has
been addressed as part of the BioCreative III challenge
[59].
Combining different identification approaches for genes
leads to a modular setup that enables shaping the out-
comes to the demands of the identification system. Both,
high recall versus high precision can be achieved through
different system setups [45]. Ultimately, the tagging solu-
tions have to comply with the lexical resources, with the
coding standards and with the GSCs for benchmarking
measurements to demonstrate the best performances.
Overview
In this study, we evaluate and compare the performance
of several PGN tagging solutions against available PGN
gold standard corpora. Then, we analyse which features of
specific PGN taggers lead to a drop in their performance,
and what characteristics of the GSCs influence their per-
formances. Furthermore, we analyse the size of the lexical
resources and the impact in their performance, and to
which extend false positive filtering improves the results.
Finally, we compare the different tagging solutions and
perform error analysis. To do so, we generate false posi-
tive and false negative profiles for each tagging experiment
and compare the profiles across tagging solutions and cor-
pora to describe the error profile that is characteristic for
each tagger-corpus pair.
Materials andmethods
In this section, we present the GSCs and annotation solu-
tions used in this work. The corpora and annotation
solutions have been standardized to a common format
(IeXML) [60], which allows an easier integration of the
different components of the experiments. The evaluation
tool used in this work has been developed and extensively
tested as part of the CALBC projecta.
Table 3 All available terminological resources have been compared against each other to identify themost
comprehensive and themost universal ones
Tagger
Match Corpus # Entries SwissProt [%] Biolexicon [%] SwissProt (GP7) [%] GP7 [%]
Exact
SwissProt 228,893 208,069 90.9% 121,369 53.0% 135,018 60.0%
BioLexicon 653,212 207,976 31.8% 243,573 37.3% 422,477 64.7%
SP(GP7) 868,050 121,030 13.9% 243,271 28.0% 860,094 99.1%
GP7 1,725,500 134,275 7.8% 421,520 24.4% 859,536 49.8%
Alias
SwissProt 228,893 213,009 93.0% 201,633 88.1% 206,047 90.0%
BioLexicon 653,212 229,759 35.2% 375,550 57.5% 585,205 89.6%
SP(GP7) 868,050 219,185 25.3% 364,171 42.0% 865,590 99.7%
GP7 1,725,500 267,947 15.5% 644,115 37.3% 956,314 55.4%
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Gold standard corpora
Gold standard corpora have different profiles, e.g. size,
topic, release date, and annotation guidelines that will
impact the performance of the tagging solutions. Table 1
contains statistics of the different selected corpora.
The Jnlpba corpus is based on the Genia corpus [22],
which contains annotation for different entity types linked
to molecular biology such as PGN, cell type, and cell line,
all being compliant with the Genia ontology.
The BioCreative-II corpus covers human genes and
proteins and contains sentences instead of complete
Medline abstracts [61]. It makes use of an alternative
gene-list in addition to the regular list of genes for exam-
ple, the GL (= GeneList) contains
(1) P00027967A0207 | 11 31 | secretory HI
antibodies,
while the AGL (= Alt Gene List) also includes:
(2) P00027967A0207 | 11 21 | secretory HI,
(3) P00027967A0207 | 20 21 | HI, and
(4) P00027967A0207 | 20 31 | HI antibodies
for the same annotation example.
The Medline abstracts in PennBio have been developed
with a focus on oncology [24]. The FsuPrge corpus is the
largest of all and has a focus on molecular mechanisms
such as gene regulation.
Tagging solutions
We have tested several tagging solutions, with different
underlying approaches. First, we have used state of the
art ML-Tag approaches for gene mention identification.
Second, we have used standard LexTag solutions where
different terminological resources for PGNs have been
integrated with and without disambiguation techniques.
Last, we have combined the first and the second type to
filter out false positives after dictionary lookup.
The ML-Tag approaches comprised Abner (BC1)
trained on BioCreative-I, Abner (Jnlpba) trained on
Jnlpba, and two taggers trained on BioCreative-II (Banner,
“Chang2”) based on Conditional Random Fields (CRF)
[20,62]. The Banner tagger has been downloaded from
the distribution siteb. The Chang2 tagger is a CRF model
trained on BioCreative-II data with a set of features as
given in [62]: (1) all character n-grams of length 2 to 4,
(2) inclusion of capitalization (token starts or ends with a
Capital letter, or Capital letters only etc.), (3) length of the
tokens (one character, two characters, between three and
five), (4) inclusion of digits (1 digit, 2 digits, only digits),
and (5) contained punctuation symbol or a Greek char-
acter. In addition a contextual window of plus or minus
2 tokens is employed (called “offset conjunctions”). The
model is implemented as CRF (using mallet).
For the LexTag solutions, we tested publicly avail-
able Whatizit modules from UKPMC and other research
(cf. Table 2) [27,63]. In addition, we have compared the
two latest versions of the Biothesaurus (version 6.0 and
7.0, GP6 and GP7, respectively) as part of the exist-
ing solutions to identify the importance of the lexical
resource.
SwissProt (SP) is the Whatizit-SwissProt module inte-
grated into different textmining solutions such as EBIMed
[64] and PCorral [65]. It uses terms retrieved from the
SwissProt subset of UniProtKb obtained in 2007. SP(GP7)
is the updated version, which comprises the full selec-
tion of SwissProt PGNs from Biothesaurus 7.0. The tag-
ging of genes applies morphological variability to terms,
i.e. accepting separators ([- /]), initial capitalization,
and singular-plural variability (“alias matching”), since
this morphological variability is very common in the use
of gene names [66]. This approach is similar to approxi-
mate stringmatching, e.g. Levenstein distance, but ismore
specific and thus better suitable for the comparison of
PGN terms. Alternative methods include the automatic
generation of a large dictionary resource containing all
terms exposing the same term variability and then apply
exact matching [42].
Finally, all tagged PGNs will be removed that are too
unspecific, i.e. those terms that are part of the general
English language and would be difficult to attribute to a
specific gene or protein. This approach applies to all PGNs
that appear in the British National Corpus (BNC)c with
a frequency rate that is higher than the one of “insulin”
(“basic disambiguation” or “BNC disambiguation”). It has
been used in all LexTag solutions.
The GP7 solution makes use of the full content from
Biothesaurus 7.0, applies morphological variability and
basic BNC disambiguation only. Biolexicon integrates the
full BioLexicon content into the same approach. The two
solutions Wh-Ukpmc and Wh-Ukpmc (GP7) implement
the same solution as before with Biothesaurus 6.0 and 7.0,
respectively, and in addition we apply FP filtering with
the Chang2 tagger after the basic BNC disambiguation to
increase precision (“false positive filtering”).
The Table 3 gives an overview on the content used for
building the dictionary-based solutions and demonstrates
how the lexical resources differ in their size and content.
The comparison makes use of exact and alias matching
(see above) where a dictionary is incorporated into a lex-
ical tagger (see above) for the matching of terms in the
other lexical resource. According to our manual evalua-
tion, GP7 in contrast to GP6 exposes reduced term vari-
ability across the resource to be more compliant with the
naming standards in the biomedical research community.
In Figure 1 the small terminological resource generated
from the SwissProt part of UniProt, which only contains
228,893 terms, has been compared against two selections
from GP7, which is the version 7.0 release of the Bio-
Thesaurus forming the largest lexical resource for gene
names. The figure visualizes the portion of SP that can be
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Figure 1 The tagging solutions have been used to annotated the lexical resource to determine how they comply with naming standards.
The figure shows the tagging of entries from larger dictionary resources (SwissProt (GP7), GP7) against the smaller lexical resource (SwissProt). When
using exact matching, only about 53% and 60% of the terms in the smaller resource can be identified by SwissProt (GP7) and GP7, respectively;
whereas 88% and 90%, respectively, have been tagged when using alias matching. The same results are produced when using the small lexical
resource as tagger against the larger lexical resources. The first experiment using exact matching demonstrates that the larger lexical resource uses
slightly different notation standards which can be ignored when using alias matching. It is also remarkable that the smaller lexical resource seems to
be already very effective in the tagging of the genes in the corpora indicating that the core terminology for gene mentions is already included in a
comprehensive way.
matched by GP7 terms in exact and alias matching and
shows how the two lexical resources differ in their nam-
ing standards, how this difference disappears under alias
matching and that – in the latter case – almost all terms
from SP are covered by GP7. This comparison shows that
the corpora match a significant portion of core terms that
are already included in the SP lexical resource.
Finally, the Gnat gene mention tagger and the gene nor-
malization solution have been tested against the corpora
[42]. The Gnat gene normalisation mode has been used,
since the gene mention mode of Gnat is based on Banner.
The tagger has been applied in different modes using only
the dictionary for human genes (GNAT/hum.) or for all
species (GNAT/all).
In the latter case, the full set comprises 11 dictionaries
for human and the most common model organisms (in
total 80,000 entries).
Evaluation
For all tagging experiments against the corpora, we have
calculated Precision, Recall and F-measure defined as:
Precision P = |XI∩XM|XI , and Recall R =
|XI∩XM|
XM , where XI
is all entities identified by the PGN taggers and XM is all
entities which are (manually) annotated in the GSC. The
F1-measure has been calculated as 2PRP+R .
In addition, and in order to obtain a better understand-
ing of the similarities and differences of the taggers, we
have collected and counted the FP and FN results sep-
arately, sorted them according to their frequency and
selected the most frequent errors for our analysis (N =
100, (Additional file 1): Tables S10, S11, S12 and S13). The
FP results from all experiments have been normalized to
produce the representation of the FP profile, i.e. the FP
results from each corpus formed a single entry in the nor-
malized vector. The FP profiles were populated with the
FP error frequency and have then been used to measure
the correlation between the error profiles. The FN pro-
files were produced in the same way using the FP error
frequencies. The same profiles were exploited for the sim-
ilarity comparisons as well as clustering of the results
(using R × 64 2.1.4.0), based on a hierarchical cluster-
ing where at each iteration step the distances between the
clusters is determined by the Lance-Williams dissimilarity
update formula and by the complete linkage method that
supports identification of similar clustersd.
To calculate precision, recall and F1-measure, the eval-
uation of the annotated documents against the corpora
has been performed with exact matching, but as well with
a more relaxed matching approach named cos98 match-
ing [31]. For the cos98 matching, all the tokens in the
text receive a weight according to their inverse docu-
ment frequency across the Medline corpus. The similarity
of two annotations is calculated as the cosine similarity
between all tokens and their weights in the two annotated
strings. A high cos98 (cosine similarity > 0.98) score is
achieved if the two annotated strings differ only by terms
with a low information content, such as “the” or “pro-
tein”. In the case of BioCreative-II, only the gene list has
been considered during exact evaluation, and the whole
gene list in combination with the alternative gene list
has been used for the correlation in the cos98 match-
ing evaluation. All results and descriptions of the used
systems are also available through the CALBC League
Table [67].
Since the lexical resources – in essence – have been
derived from the biomedical reference databases, they are
considered to represent the domain knowledge. If a Lex-
Tag solution produces a low FN error rate on a GSC then
we call the tagger complete with regards to the corpus. If
a LexTag solution produces a low FP error rate on a GSC
then we call the corpus complete with regards to the tag-
ger. If both conditions are true, then we call the tagger
compliant with the corpus.We call two PGN tagging solu-
tions compliant, if they are compliant against the same
corpus. If they only have very similar FP and FN profiles
against a corpus, we call them replaceable.
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Categorisation of FP and FN results
For better assessment of the FP and FN results, a selection
of the 15most frequent FP and FN results, respectively, for
all pairs composed of a corpus and a tagging solution has
beenmade. This approach is suitable for the two following
reasons. First, it allows comparing the corpora, although
the corpora have different sizes and different annotation
standards, and thus they produce different amounts of
errors which limit their comparability if all FP and all FN
results have been considered. And second, the removal
of the most frequent mistakes is a common approach to
improve the quality of a tagging solution against a corpus.
We can expect – from a theoretical point of view –
that the tagging solutions will produce similar FP results
across the different corpora under the assumption that the
corpora have been extracted from the same collection of
documents. In our case, all corpora stem from Medline
abstracts, but the topic of each one of themmay differ. On
the other hand, we would expect very similar FN results
only for any single corpus but not necessarily across all
corpora, since the corpora do not exactly follow the same
annotation standards.
The terms forming the most frequent FP and FN errors
have been manually analyzed and categorized into dif-
ferent sets (see Table 4). The selected categories con-
sider morphological and semantic differences and again
induce an abstraction of the findings to support compa-
rability between the different corpus-tagger experiments.
Furthermore, the different error types have been sorted
according to the categories “Core”, “Margin” and “Arte-
fact” of decreasing relevance for the PGN tagging task.
Artefacts are general English terms, expanded a-PG, since
they convey a modified semantics, and single charac-
ters, which do not sufficiently abbreviate a PGN. Terms
in the category BMT, ea-PG and 2C do represent PGNs
as generalizations or family terms, as modified a-PGs or
intermediary forms between PGT and a-PG, and as very
short a-PGs, respectively. The core terms certainly should
be fully annotated in a corpus, and should be completely
identified by a PGN tagging solution. All FP and FN
results have been categorized and the counts have been
normalized based on the total number of annotations in a
corpus to yield representative and comparable figures.
Results
In this manuscript, we present the results from a
study comparing different PGN tagging solutions against
all available GSCs and measuring performances. This
research enables a better understanding, what contri-
butions for the tagging performances can be expected
from the components of a PGN tagging solution. Further-
more – by analysing the FP and FN errors – we explore
the characteristics of the erroneous annotations by the
different solutions.
Comparison of the lexical resources
The lexical resources differ in size and content, and also
differ in the terminology that is shared between them
when performing comparisons (cf. Table 3). The largest
lexical resource, i.e. GP7, comprises 1,725,500 unique
terms, whereas the smallest one, i.e. SwissProt, comprises
only 228,893. Even the change from one version to the
next, i.e. from GP6 to GP7, can lead to a strong increase
of unique terms and term variants. Manual inspection has
shown that GP7 incorporates a larger number of general
English terms as term variants [12]. The different lex-
ical resources are homogeneous in the sense that they
share significant portions of their content, and it can be
expected that the larger resources improve the recall of
LexTag solutions.
Evaluation of taggers across corpora: F1-measures
All supervised solutions show their best performance
against those corpora that have been used for their train-
ing and lower performances against the other corpora.
Banner shows the best performance in comparison to
all the other PGN taggers, if we consider BioCreative-II
only (exact and cos98 matching evaluation), i.e. Banner is
Table 4 This table gives a schema for categorizing terms into different types that help to sort and count themost
frequent false positive and false negative results
Label Description Semantics Relevance Examples
1C 1 character Undefined Artefact N
2C 2 characters Undefined Margin T3, PU, LH
a-PG Acronym PGN Confirmed by UniProtKb Core Ras, c-fos, Wnt
ea-PG Extended a-PG a-PG with preserved semantics Margin Ras gene, p53 protein, Src family
xa-PG Expanded a-PG a-PG with modified semantics Artefact p53 mutations
PGT Protein/gene term Confirmed by UniProtKb Core E-cadherin, beta-catenin, glucocorticoid receptor
BMT Biomedical term Specific to biomedical scientific text, excluding PGT Margin olymerase, prion, IgM
GE General English term Occurring in non-scientific text Artefact Plasma, renal, inhibitor, antibodies
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compliant with BioCreative-II (seeMaterials andmethods
section). The Chang2 PGN tagger shows similar but
slightly lower performance on the same corpus. It can
be as well considered compliant with BioCreative-II, but
would also profit from optimisation to reach the per-
formance of Banner at the expense of lower precision
(cf. Figures 2 and 3).
On the FsuPrge corpus, Banner performs best but only
when cos98 matching is applied, and its performance is
still lower than four of the six Lex-Tag solutions (for exact
matching, cf. Figure 4). On PennBio and Jnlpba, Banner
is not the best performing solution and even Chang2 per-
forms better (except for PennBio, exact matching). Note
that Abner(BC1) has been trained on BioCreative-I and
shows the best performance against the BioCreative-II test
corpus indicating that similar annotation guidelines apply
to both corpora.
When using cos98 matching – in contrast to exact
matching – the performance of the tagging solutions
increases (5% to 10%, cf. Figure 4). As a result the per-
formance differences between the individual PGN taggers
measured against a single corpus become smaller for all
corpora. More in detail, on FsuPrge and PennBio the
differences are reduced to less than 10% (cos98 match-
ing), except for the Gnat solutions and for Abner on
PennBio.
One reason for this change could be that PennBio and
Jnlpba follow different naming conventions in comparison
to current lexical resources. Cos98 similarity relaxes the
importance of term variability in the evaluation against
the PGN mention boundaries in the corpus. This has
already been acknowledged in the BioCreative-II chal-
lenge through the introduction of an alternative gene list,
which accomplishes the regular gene list (cf. Figure 5)
[23].
When considering the alternative gene list, the per-
formance of the tagging solutions increases similar to
the cos98 evaluation on the other corpora. Selected data
entries on the alternative gene list, which are marked as
‘**TP’ in the evaluation result, are only recognized by the
ML-Tag solutions‘and may have been added at a different
time point than the other entries.
The performance of GNAT is lower than the one from
the other solutions. This result is expected, since GNAT
performs gene normalisation, i.e. it anticipates assigning
a small selection of identifiers or a single identifier to the
protein mention, which is a more complex task than gene
mention annotation and automatically leads to reduction
in recall.
Precision and recall evaluations
When comparing the precision and recall performance of
the tagger (cf. Figure 6), both Banner andChang2 show the
best performance against the BioCreative-II test corpus.
The best performing LexTag solutions either show high
recall, in particular if they incorporate the latest version of
the Biothesaurus (GP7), or high precision if they use either
a small lexical resource, for example the SwissProt tag-
ger, or if they make use of efficient FP filtering as it is the
case for Wh-Ukpmc. Again, cos98 matching gives higher
precision values than exact matching indicating variabil-
ity in the gene mention boundaries (see BioCreative-II,
alternative gene list).
Comparing the PGN taggers across the different cor-
pora leads to the conclusion that the performance on one
corpus is predictive for the others (with a few exceptions),
i.e. the order of corpora with regards to the performance
is preserved across the different taggers, keeping in mind
that the ML-Tag solutions perform best on the test cor-
pora of theGSC used in their training. It is also remarkable
that the recall performances of FsuPrge and PennBio are
less than 5% apart across the different tagging solutions
(apart from Abner (Jnlpba) and BioLexicon), indicating
that PennBio and FsuPrge may comply better with the
naming guidelines for gene entities.
Comparing FP and FN profiles between tagging solutions
FN results are indicative for the corpus
The error profiles of four taggers have been analysed to
explore the response of the taggers against the GSCs. The
Figure 2 All taggers have been tested against all GSCs using cos98 similarity for evaluation (see also Figures 4, 5 and 6).
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Figure 3 Again all taggers have been tested against all corpora, but now exact matching has been applied for evaluation. The table shows
the same performance results as Figure 2 with the difference that exact matching has been used as evaluation form (see also Figures 4, 5 and 6).
FN errors of the annotations have been extracted and
compared (exact evaluation, cf. Figure 7). The results from
the tagging solutions can be compared due to the reuse
of similar lexical resources at different sizes and the reuse
of the Chang2 tagger as FP filter. As mentioned above the
comparison is done based on hierarchical clustering (see
Materials and methods section).
Since the FN results are defined by the corpus anno-
tation standards, the taggers cluster together accord-
ing to the corpus which they have been tested on,
i.e. the tagging solutions produce similar FN results
and can be called complete towards a given corpus
if they produce a small number of FN results (see
Materials and methods section). In addition, the FN
results of the Chang2 tagger and Banner are very sim-
ilar, since both have been trained on the same corpus,
but the FN errors of SwissProt and Wh-Ukpmc(GP7)
cluster as well together. Both have very similar preci-
sion and recall performances, and include similar lexical
resources.
A more detailed analysis of the FN errors is given
in Figure 8: the 15 most frequent FN errors for each
corpus-tagger pair have been manually categorized into
different groups according to their morphological and
semantic criteria (see Materials and methods section).
Three kinds of FN errors dominate the outcome: (1)
missed acronyms (a-PG), (2) missed long-form PGNs
(PGT) and (3) missed unspecific biomedical terms
(BMT).
GenProt 7.0 (GP7) has the highest recall and thus the
lowest number of FN errors due to its large terminolog-
ical resource. Considering PennBio, the other three tag-
gers miss mainly the acronym forms of the PGNs, which
hints towards completeness of the corpus with standard
Figure 4 The diagram shows the F1-measure performance of the different PGN taggers against the selected corpora using exact as well
as cos98 evaluation. TheML-Tag solutions have been trained on BioCreative-II (Banner, Chang2), on BioCreative-I (Abner (BC1)) and on Jnlpba
(Abner (Jnlpba)) and therefore perform best on these corpora. The LexTag solutions show similar performance across all corpora. In the left diagram
all solutions have been measured using exact matching against the entity boundaries in the GSCs; for BioCreative-II only the gene list has been used
for the evaluation. The measurements in the right diagram use a relaxed measure based on cosine similarity (cos98) between the tagged results and
the GSC annotations leading to higher F1-measures; for BC2 the gene list and the alternative gene list has been applied. In both diagrams, the the
entries in the left third represent theML-Tag solutions, the middle part the LexTag solutions and the right part the Gnat solutions as a reference to a
gene normalisation tagger. The performances of the LexTag solutions against the corpora reach higher F1-measures for FsuPrge and PennBio than
for BioCreative-II and Jnlpba.
Rebholz-Schuhmann et al. Journal of Biomedical Semantics 2013, 4:28 Page 11 of 18
http://www.jbiomedsem.com/content/4/1/28
Figure 5 The three diagrams show the evaluation of the different tagging solutions against the BioCreative-II corpus only. For the
evaluation represented by the solid line only the gene list of the BioCreative-II evaluation kit has been used. For the two other lines also the
alternative gene list has been applied counting the ‘*TP’ (dotted line) and the ‘**TP’ (dashed line) as TP candidates (instead of FP candidates). From
the first to the last evaluation all three measures improve, and only theML-Tag solutions profit from the ‘**TP’ data entries in the alternative gene list
of BioCreative-II. Obviously these candidates are not part of any lexical resource and only occur in the BioCreative-II corpus.
acronyms. For other corpora, i.e. for FsuPrge and Jnlpba,
the FN errors fall into the PGT category, which in general
show high diversity.
Furthermore, the error profiles for FsuPrge across all
tagging solutions show high similarity indicating that this
corpus is complete in its annotation and thus robust
against alternative tagging solutions. PGN tagging solu-
tions have the lowest number of FN errors on the
BioCreative-II corpus, indicating that this corpus is com-
plete with regards to the tagging solutions. On the other
hand, the SwissProt tagger generates across all corpora the
same FN errors and is thus more consistent across all the
corpora.
The four diagrams in Figure 9 give an overview on
the normalized distribution of FN errors across the four
different corpora. Jnlpba is the only corpus generating
general English (GE) FN mistakes indicating that Jnlpba
deviates from the standard in the other corpora, but
all corpora do induce FN results that are categorized
as biomedical terms (BMT). This category gathers those
terms that are considered to represent less specific terms
than PGN mentions. Cos98 matching partially resolves
boundary mismatches, and therefore reduces the FN error
rates in PennBio, in particular for Chang2 and GP7, but
also in BioCreative-II.
Overall, it can be concluded that BioCreative-II and
FsuPrge are better compliant with the naming conven-
tions in the biomedical domain than the other two cor-
pora, i.e. induce FN errors due to GE and BMT terms at
a lower rate. In particular FsuPrge generates comparable
FN profiles across the different tagging solutions, indicat-
ing that less common PGT and a-PG terms are difficult to
capture for all tagging solutions.
On the other side – as pointed out before – all corpora
are predictive for the performance of the tagging solutions
alike (see above).
Figure 6 The precision and recall performances in these diagrams are based on cos98 evaluation. The left and the right diagram give an
overview on the precision and recall measurements of the PGN taggers against the selected GSCs. ForML-Tagmethods both parameters are best, if
the taggers have been tested against those corpora that they have been trained on. The LexTagmethods have been sorted from left to right
according to their precision performance with the best performing solution to the left. With minor deviations, all LexTagmethods show best
performances against the FsuPrge corpus for both, precision and recall. The “trade-off” between precision and recall for methods with similar
F1-measures is well known, but it is still remarkable that the LexTag solutions can differ considerably on their precision and recall values, whereas the
F1-measure seems to be almost invariable across them. Again, precision and recall performances of the LexTag solutions against the corpora reach
higher values for FsuPrge and PennBio than for BioCreative-II and Jnlpba.
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Figure 7 Clustering has been applied to determine the similarity of the tagging solutions based on the FP and FN profiles determined on
the different GSCs. The most frequent 100 FNs and FPs, respectively, from all annotations for a given corpus have been used to characterise the
performance of a PGN tagger against the different corpora (GP7: GeneProt7, Wh.GP7: Wh-Ukpmc (GP7)). Four taggers have been selected that are
closely related due to their components. The comparison of their FP and FN errors, respectively, or their FP and FN profiles, will help to trace back
types of errors to the composition of the tagging solutions. The error profiles have been clustered according to their FN profile similarity (left
diagram) and their FP profile similarity (right diagram). – Chang2 and Banner profiles always cluster together, since they rely on the same
technology. The FN profiles of the taggers cluster together according to the corpus which has been used to test them, since the FN errors are
predefined by the annotation standards of the corpus, i.e. by the pre-assigned annotations missed by a tagger. When we take the FP profiles into
consideration, the taggers cluster together across the different corpora. Here, it is also remarkable that SP and Wh7 cluster together, although they
do differ in terms of their resources.
FP results are indicative for the tagging solutions
FP errors represent those PGN mentions that have been
identified by the tagging solution but do not match the
annotations in the GSCs. Collecting and analyzing the set
of false positives for each tagger and corpora pairs gives
further insight for the types of errors produced by each
tagger and for potential deficits in the annotation stan-
dards for the corpora. Clustering the FP profiles of the
tagging solutions (cos98 matching, cf. Figure 7) reveals
that – as expected – Chang2 and Banner produce
similar FP results. Apart from this, Wh-Ukpmc(GP7)
and SwissProt cluster together on the different corpora
because they use similar terminological resources. Gen-
Prot 7.0 is clearly distinct from the other tagging solutions
due to its high false positive rate.
The Pearson product-moment correlation coefficient
has been determined for the different pairs, where each
pair is composed of a PGN tagger and a corpus. The
correlation calculations are based on the false positives
results produced by the combination of a PGN tagger and
a corpus (see Figure S9, in the Additional file 1). The
correlation matrix shows the pair-wise similarity of the
Figure 8 The diagram gives an overview on the most frequent FN results. The FN results have been categorized according to the morphology
and the semantics of the missed terms. For all GSCs and the different tagging solutions the counts for the 15 most frequent FN errors are shown.
Since PennBio and FsuPrge are the largest GSCs, they induce also a larger number of FN results. FN results of GE terms are mainly encountered in
Jnlpba. FsuPrge generates a larger portion of PGT FN results, whereas PennBio mainly leads to a-PG FN results.
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Figure 9 The diagram displays the portions of FN results of the tagging solutions against the GSCs. The figure visualises the results from
Figure 8, where the error frequencies have been normalized by the annotations contained in the GSC. The FN errors in Jnlpba and in FsuPrge are
frequently of type PGT, whereas the other two corpora rather produce a-PG FN results. PennBio and Jnlpba appear to be less compliant with the
terminological standards of the tagging solutions than the other two corpora. Exact matching and cos98 matching produce very similar results,
excluding that the selection of annotation boundaries could be the main source of the FN results.
taggers across the different corpora with the strongest cor-
relations given between Wh-Ukpmc(GP7) and SwissProt
on PennBio, BioCreative-II and Jnlpba, and between
Chang2 and Wh-Ukpmc(GP7) across the different cor-
pora. This could be due to the use of the same FP filtering
in both solutions. Again, GeneProt7.0 (GP7) is clearly
distinct due to the lack of efficient FP filtering.
The Chang2 tagger generates the smallest number of
false positives, thus showing high precision across the
different corpora. Its FP results can be grouped into
acronyms (a-PG) or long-form (PGT) PGNs. On the other
hand, the GP7 tagger generates a significant amount of
false positives that can be classified as other biomedical
terms and general English terms (see Figure 10). This is in
particular true for the FsuPrge corpus indicating that most
a-PG and PGT terms have been identified.
SwissProt and Wh-Ukpmc (GP7) show very similar
results in FsuPrge and BioCreative-II again indicating that
both corpora follow the same naming standards; and both
show a slightly more complementary distribution of FP
errors in Jnlpba and PennBio. This result shows that Wh7
produces a higher number of FP errors in the categories
BMT andGE, which cannot be compensated through false
positive filtering, since Chang2 is optimized for long-form
and acronym PGNs in contrast to other biomedical terms.
From a methodological point of view, Wh-Ukpmc(GP7)
has the advantage of a large lexical resource in com-
bination with a precise ML-Tag solution for FP fil-
tering, however, SP performs evenly well, although
the terminological resource in SP has been kept to
the standard of previous years. The best explanation
is that the lexical resource of SwissProt incorporates
the “conserved” part of the different terminological
resources and generates only a small number of FP
results.
Figure 11 shows the normalized FP errors taking the
number of annotations into consideration. Taggers on
the FsuPrge corpora produce the smallest FP error rates
with exception of the GP7 tagging solution (above 12%),
and BioCreative-II generates a similar result with a lower
error rate for GP7 (below 10%). This difference can be
explained by the fact that FsuPrge covers full abstracts
whereas the BioCreative-II corpus is composed of sin-
gle sentences, which increases the rate of specific terms
over unspecific terms in the corpus. PennBio and Jnlpba
include a higher FP error rate for a-PG and even the
Chang2 tagging solution has a FP error rate of above 5%
on the 15 most frequent FP errors showing that Jnlpba
follows slightly different naming conventions than the
other corpora.
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Figure 10 The overview lists the most frequent FP results according to predefined categories. The FP results have again been categorized
according to the morphology and the semantics of the missed terms (see Figure 8 above). Again, for all GSCs and the different tagging solutions the
counts for the 15 most frequent FP errors are displayed. GP7 and Wh-Ukpmc (GP7) are based on a very large terminological resource that generates
BMT and GE FP errors in larger numbers. FP filtering with Chang2 reduces the rates in the case of GP7. The profile of Chang2 differs from the others
in the sense that it generates ea-PG and xa-PG FP errors increasing acronyms to larger term structures.
FP and FN error distribution according to their relevance
The last analysis qualifies the FP and FN mistakes into
categories, where each category is attributed a level of
relevance for the PGN tagging task. The idea behind this
approach is the observation that it is of higher impor-
tance to identify specific types of PGNs, e.g. the acronyms
and the long-form mentions of PGNs (a-PG and PGT), in
contrast to other mentions of PGNs, e.g. single character
PGNs and terms representing general English concepts.
In a more strict sense, if a corpus represents well the
best conserved PGN terms and a tagging solution iden-
tifies them at a high performance measure, then this
solution would fulfill the tagging task more reliably in
comparison to either a corpus that has a higher vari-
ety of PGN annotations and misses out on well con-
served PGN terms, or in comparison to a PGN tagging
solution that rather identifies less specific terms (e.g., GE
or BMT terms) or modifications of a-PG terms (e.g. ea-
PG or xa-PG) in contrast to the most conserved PGN
terms.
When regarding the FN results (cf. Figure 12), it
becomes clear that only very few FN errors can be found
that are classified as artifacts.We can expect that the cura-
tors have excluded annotations that would be categorized
as artifacts, since this type of annotations are unspecific
for PGNs. On the other side, the tagging solutions do
produce FP errors in this category including the ML-Tag
solution Chang2, and most FP errors occur if a large ter-
minological resource is applied unfiltered (see GP7 in
Figure 12).
When analysing the annotations that are classified as
“Core”, we discover that the biggest number of FN results
Figure 11 The diagram displays the FP results of the tagging solutions in form of error frequencies normalized against the annotation
numbers in the GSC. As expected, GP7 produces lot of FP errors in all corpora which have been reduced in Wh-Ukpmc (GP7) through FP filtering
using Chang2. All solutions produce larger numbers of FP errors in Jnlpba and PennBio leading to the conclusion that both corpora are less
compliant with the current terminological standards in the tagging of PGNs.
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Figure 12 The error in the tagger-corpora pairs have been categorized according to their relevance. The error types and counts from
Figures 8 and 10 have been grouped into the categories “Core” (for a-PG and PGT), “Margin” (for 2C, ea-PG, BMT) and “Artefact” (for 1C, xa-PG, GE)
representing different levels of relevance for the PGN tagging task. The FN results are on the left, the FP results are to the right, the upper part
contains the absolute numbers and the lower figures have been normalized according to the total number of annotations in the corpora. Only the
results for the cos98 evaluation are shown.
occur in absolute and relative numbers on PennBio even
for different tagging solutions, indicating that the anno-
tations may not be conform with the standard biomed-
ical data resources (non-compliant annotations). When
considering Wh-Ukpmc (GP7) and SwissProt, a high
portion of FP annotations belonging to the category
“Core” can again be found for PennBio and Jnlpba,
which indicates that not all PGN mentions have been
annotated.
For the GP7 annotation solution we find that it over-
generates annotations due to the lack of FP filtering for all
corpora. On the other side, the BC2 corpus and FsuPrge
do annotate the domain terminology well (inducing a
small number of FN results), and also capture all PGN
findings in the corpora, leaving little room for FP mis-
takes.
Discussion
The presented analysis gives an overview on the differ-
ent PGN tagging solutions against the GSCs. As expected,
we can judge the tagging solutions against the GSCs,
but – in principle – we can also judge the GSCs against
the tagging solutions. For the former case, we learn that
the annotations in the GSCs differ from each other leading
to different FN profiles when measuring the performance
of the taggers against the corpora. From the FP pro-
files, it is possible to derive that the corpora differ in
their degree of completeness with regards to the tagging
solutions.
Judging the tagging solutions
According to the FP rate of the taggers against the dif-
ferent GSCs allows for a better understanding of their
working and propose approaches for their improvement.
For example, the GP7 LexTag solution annotates a larger
number of general English terms, e.g. “kinases”, which
may or may not be relevant for the overall annotation of
gene entities, but which in general is not included in the
annotations of the different corpora (cf. Additional file 1:
Tables S12 and S13).
As expected, the ML-Tag solutions perform better on
the test set of the GSCs used for their training data,
however they do show mediocre performance on the
other corpora. In addition, theML-Tag approaches do not
deliver any clues for the normalization of the identified
protein or gene entity. The biggest advantage of the ML-
Tag approaches lies in the context-sensitive disambigua-
tion of entities. This characteristic has been exploited
in our experiments to improve the results of the LexTag
solutions through FP filtering and showed the beneficial
positive results. It became also clear that this FP filter-
ing did not effectively work for general biomedical and
general English terms, which were not recognized as FP
annotations.
Applying FP filtering to the LexTag solutions increases
precision and reduces recall as shown by our experi-
ments, however it is not obvious what the best combi-
nation should be. More in detail, the different LexTag
approaches produced very similar F1-measure perfor-
mances, although they differ in their FP and FN profiles. A
priori, it is an advantage to use a large lexical resource to
increase the recall, but as can be seen from our results this
approach largely reduces the precision. Fortunately, in the
case of high recall and low precision, it is possible to apply
FP filtering to the LexTag solution for lowering high recall,
improving low precision and eventually the F1-measure
performance after all.
The ML-Tag approaches reproduce the corpus annota-
tions and have the following characteristics: (1) they can
identify terms that might not be included in any lexi-
cal resource, (2) can cope with terminological variability,
and (3) might still ignore a gene mention, if the context
lacks to deliver the right clues. The combination of LexTag
and ML-Tag solutions give the opportunity to combine
efficient gene mention identification with gene normal-
ization, and gene mention methods should perform better
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than gene normalization, since not all gene mentions are
known to the lexical approach.
Judging the GSCs
The PennBio corpus and the FsuPrge corpus are the
two corpora where the taggers tend to deliver their best
performance. This could be explained by the fact that
both corpora have been created more recently than the
BioCreAtIve-II and the Jnlpba corpus and therefore they
may better comply with naming conventions in the bio-
logical domain, i.e. comply better with latest annotation
guidelines for genes and proteins.
The analysis of the FP and the FN errors has demon-
strated that BioCreative-II and FsuPrge are more com-
pliant with the terminological resources than the other
two corpora are. It is surprising that the tagging solu-
tions perform worse on the BioCreative-II corpus than on
the FsuPrge corpus, but this can be explained by the fact
that the single sentences in the BioCreative-II corpus have
been selected in a way which is very specific to biomedical
text mining, or – the other way around – the context in
the FsuPrge full Medline abstracts contains a higher diver-
sity of non-specific terms which reduces the performance
of the tagging solutions.
When comparing the evaluation based on exact match-
ing to the one from cos98 matching, the performance
of all tagging solutions improves, but their relative per-
formance against the different corpora stays the same,
i.e. the order of the corpora measured by the performance
against any given tagger is unchanged. In particular, the
performance of the tagging solutions measured against
Jnlpba and BioCreative-II improve when moving from
exact to alias matching. This shows that these two cor-
pora comprise more term variability in their annotations
in comparison to the other two corpora, in particular since
both corpora are smaller in their size.
The annotated corpora and the used terminological
resources have been produced at different time intervals.
As a result, a lexical resource from the past should be
more compliant with a corpus that is outdated as well.
This assumption could not be confirmed. It is rather the
case that a larger lexical resource contains more spu-
rious terms, generates more noise induced by the FP
errors in the tagging results, and that other parameters
are more relevant for the terminological variability in
the corpora such as the annotation guidelines. Although
the distinction between gene acronyms only and long-
form PGNs on the one side, and between the genes in
general and biomedical terms or general English terms
can be difficult, we could identify that the identifica-
tion of a-PG terms is best performed with a ML-Tag
solution whereas the other forms are better identified
with LexTag solutions including morphological or even
syntactical variability.
Conclusion
The following findings can be drawn from our study. The
ML-Tag approaches work best on the corpus where they
have been trained on, which has been expected in the
first place. Chang2 has been trained on BioCreative-II
and performs best on BioCreative-II. Abner (BC1) used
the BioCreative-I corpus and shows best performance
on BioCreative-II. Abner (Jnlpba) has its best results on
Jnlpba where it has been trained on. Unfortunately, their
performances drop when moving to a different corpus.
These results show that the tagger performances highly
depend on the corpora that they have been trained on and
thus they cannot generalize well from the learning corpora
to the other corpora.
The LexTag solutions have different profiles for their
precision and recall performances, but the F1-measure
remains in a very similar range. This result is surpris-
ing and suggests that they all cover a portion of the best
known naming standards, but cope differently with the
term variability across the corpora.
The FP filtering does improve the results by increasing
the precision of the LexTag solution without compromis-
ing the recall too extensively. This improvement is best
if the LexTag solution delivers high recall already at the
expense of low precision. Nonetheless, this approach still
leads to lower performance in comparison to ML-Tag
solutions only, which is again due to the fact that the
ML-Tag solutions are performing better on the context-
sensitive disambiguation and selection of annotation
boundaries.
Finally, the topic and the structure of the corpus play
an important role. BioCreative-II has a very narrow focus
to specific biomedical sentences, which differs from the
language in the other three corpora where contextual non-
biomedical terms increase the FP error rate. This has to be
considered when optimising tagging solutions against the
given corpora.
As an overall conclusion, we suggest that the right
selection of a LexTag solution can help to optimize the
text mining output either for higher precision or for
higher recall. If the best possible balanced F1-measure is
required, then the ML-Tag solutions would be the best
choice, but it would have to be trained on all available cor-
pora [68]. The combination of a LexTag solution and a
ML-Tag solution for FP filtering is in addition a perform-
ing approach.
Endnotes
a http://www.calbc.eu
b http://cbioc.eas.asu.edu/banner/
c http://www.natcorp.ox.ac.uk/
d http://stat.ethz.ch/R-manual/R-patched/library/
stats/html/hclust.html
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